Ceftobiprole for the treatment of infective endocarditis: A case series-Reference-Cited by-同舟云学术

Ceftobiprole for the treatment of infective endocarditis: A case series

Published:2020-03 Issue: Volume:20 Page:56-59
ISSN:2213-7165
Container-title:Journal of Global Antimicrobial Resistance
language:en
Short-container-title:Journal of Global Antimicrobial Resistance

Author:

Tascini Carlo,Attanasio Vittorio,Ripa Marco,Carozza Antonio,Pallotto Carlo,Bernardo Mariano,Francisci Daniela,Oltolini Chiara,Palmiero Giulia,Scarpellini Paolo

Publisher

Elsevier BV

Subject

Microbiology (medical),Immunology,Immunology and Allergy,Microbiology

Reference18 articles.

1. Ceftobiprole activity against Gram-positive and -negative pathogens collected from the United States in 2006 e 2016;Pfaller;Antimicrob Agents Chemother,2019

2. Ceftobiprole medocaril for the treatment of community-acquired pneumonia;Falcò;Expert Opin Pharmacother,2018

3. A randomised, double-blind trial comparing ceftobiprole medocaril with ceftriaxone with or without linezolid for the treatment of patients with community-acquired pneumonia requiring hospitalisation;Nicholson;Int J Antimicrob Agents,2012

4. Ceftobiprole medocaril (BAL-5788) for the treatment of complicated skin infections;Deitchman;Expert Rev Anti Infect Ther,2016

5. Ceftobiprole medocaril is an effective treatment against methicillin-resistant Staphylococcus aureus (MRSA) mediastinitis in a rat model;Barnea;Eur J Clin Microbiol Infect Dis,2014

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How is ceftobiprole used in Canada: the CLEAR study final results;Expert Review of Anti-infective Therapy;2024-07-15

2. Ceftobiprole mono-therapy versus combination or non-combination regimen of standard antibiotics for the treatment of complicated infections: A systematic review and meta-analysis;Diagnostic Microbiology and Infectious Disease;2024-07

3. Synergism with Shikimic Acid Restores β-Lactam Antibiotic Activity against Methicillin-Resistant Staphylococcus aureus;Molecules;2024-03-29

4. Safety and effectiveness of fifth generation cephalosporins for the treatment of methicillin-resistant staphylococcus aureus bloodstream infections: a narrative review exploring past, present, and future;Expert Opinion on Drug Safety;2023-12-25

5. New Antimicrobials and New Therapy Strategies for Endocarditis: Weapons That Should Be Defended;Journal of Clinical Medicine;2023-12-14